Brainstorm Cell Therapeutics (NASDAQ:BCLI) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research report sent to investors on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Maxim Group downgraded shares of Brainstorm Cell Therapeutics from a buy rating to a hold rating in a report on Thursday, […]
More Stories
PGIM High Yield Bond Fund, Inc. (ISD) To Go Ex-Dividend on December 26th
PGIM High Yield Bond Fund, Inc. (NYSE:ISD – Get Free Report) declared a monthly dividend on Friday, November 29th,investing.com reports....
AGBA Acquisition (OTCMKTS:AGBAU) Announces Unregistered Sales of Equity Securities
Triller Group Inc., the exact registrant as specified in its charter, revealed in a Form 8-K submitted to the Securities...
WiSA Technologies Receives Stockholder Approval for Data Vault Holdings Asset Purchase
On December 23, 2024, WiSA Technologies, Inc. (NASDAQ: WISA), a technology company specializing in licensing and technology solutions, disclosed in...
### Upexi Regains Compliance with NASDAQ Listing Rule 5250(c)(1) and Reports Financial ResultsWASHINGTON, D.C., December 20, 2024 – Upexi, Inc. (NASDAQ: UPXI) announced in a recent press release that it has successfully regained compliance with Nasda
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...
Lifeway Foods, Inc. Amends Employment Agreement with CEO Julie Smolyansky
On December 23, 2024, Lifeway Foods, Inc. (NASDAQ:LWAY) disclosed in an 8-K filing that the company entered into an Amended...
SKALE Network Price Down 21.1% Over Last 7 Days (SKL)
SKALE Network (SKL) traded 4.3% higher against the U.S. dollar during the 1-day period ending at 8:00 AM Eastern on...